VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. purchased 3.1% of their position (122.88K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.41M — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 2/27/2025ACC: 0001415889-25-005908
→
10% Owner
Since Feb 2025
+122.88K
Net shares
Net buyer
$1.41M
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
122.88K acquired
Non-Derivative Transactions5
Common Stock
Indirect
Shares
+574.00
Price / share
$10.90
Trade value
$6.26K
% of position
0.0%
2/10/2025
4.03M→4.03M
Common Stock
Indirect
Shares
+9.59K
Price / share
$10.95
Trade value
$105.04K
% of position
0.2%
2/11/2025
4.03M→4.04M
Common Stock
Indirect
Shares
+8.97K
Price / share
$11.86
Trade value
$106.40K
% of position
0.2%
2/12/2025
4.04M→4.04M
Common Stock
Indirect
Shares
+14.95K
Price / share
$11.63
Trade value
$173.87K
% of position
0.4%
2/13/2025
4.04M→4.06M
Common Stock
Indirect
Shares
+88.79K
Price / share
$11.44
Trade value
$1.02M
% of position
2.2%
2/14/2025
4.06M→4.15M
Total
Net shares
+122.88K
Net value
$1.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/10/2025 | P · Purchase | +574.00 | $10.90 | $6.26K | 0.0% | 4.03M | 4.03M |
| Common Stock Indirect | 2/11/2025 | P · Purchase | +9.59K | $10.95 | $105.04K | 0.2% | 4.03M | 4.04M |
| Common Stock Indirect | 2/12/2025 | P · Purchase | +8.97K | $11.86 | $106.40K | 0.2% | 4.04M | 4.04M |
| Common Stock Indirect | 2/13/2025 | P · Purchase | +14.95K | $11.63 | $173.87K | 0.4% | 4.04M | 4.06M |
| Common Stock Indirect | 2/14/2025 | P · Purchase | +88.79K | $11.44 | $1.02M | 2.2% | 4.06M | 4.15M |
| Total | +122.88K | $1.41M | ||||||
Derivative Transactions0
No derivative transactions reported